Australia · Delayed Price · Currency is AUD Redox Earnings Call Transcripts
Fiscal Year 2026
-
Sales grew 6.6% to AUD 674 million, with strong industrial and food segment gains and robust North American performance. Gross profit and EPS rose, supported by disciplined costs and a strong net cash position, while management anticipates upward pricing pressure and continued M&A activity.
Fiscal Year 2025
-
The meeting highlighted strong financial growth, a robust dividend, and successful acquisitions expanding both product range and geographic reach. Board governance, ESG commitments, and strategic focus on North America were emphasized, with all resolutions passed and key risks around market conditions and culture addressed.
-
FY 2025 delivered 9.4% revenue growth and strong cash generation despite subdued demand and cost pressures. Three acquisitions and organic expansion drove segment growth, with July 2025 sales and volumes up 13% year-over-year, signaling a positive start to FY 2026.
-
Revenue grew 8.6% year-over-year with robust volumes, while gross margin eased to 21.6% but remained within the historical range. Strong cash position and recent acquisitions support future growth, with stable outlook and continued above-average volumes expected.
Fiscal Year 2024
-
The meeting highlighted strong earnings growth, robust dividend payouts, and strategic expansion in North America. Shareholders approved all resolutions, and management emphasized resilience, conservative cash management, and ongoing acquisition plans.
-
Volume growth and improved gross margins drove an 11.4% increase in net profit after tax, with strong cash generation and a robust balance sheet. North America expansion, successful acquisitions, and a proprietary CRM system support future growth, though margins are expected to normalize as US and commodity sales rise.